Barbara Favola
- Democratic
- Senator
- District 40
Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered. This bill is identical to HB 1134.
Health insurance; prior authorization. Requires that any provider contract between a carrier and a participating health care provider contain specific provisions that require that if a prior authorization request is approved and services and supplies have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety issue that would affect the authorization alone or in combination with other authorizations; (iii) a combination of drugs prescribed would cause a drug interaction; or (iv) a generic or biosimilar is added to the prescription drug formulary. The bill provides that such provisions do not require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered.
Health insurance; prior authorization. Requiresthat any provider contract between a carrier and a participatinghealth care provider contain specific provisions that prohibit thecarrier from revoking, limiting, conditioning, modifying, or restrictinga prior authorization if such prior authorization request has beenapproved and services, drugs, or supplies have been provided or deliveredto the patient consistent with such prior authorization unless thereis evidence that the request was approved based on fraud or misinformation.The bill also extends from 30 days to 90 days the period of a member'sprescription drug benefit coverage under a new health plan duringwhich a carrier is required to honor a prior authorization by anothercarrier.
Acts of Assembly Chapter text (CHAP0338)
Approved by Governor-Chapter 338 (effective 7/1/24)
Governor's Action Deadline 11:59 p.m., April 8, 2024
Enrolled Bill Communicated to Governor on March 11, 2024
Impact statement from SCC (SB98ER)
Signed by President
Enrolled
Signed by Speaker
Bill text as passed Senate and House (SB98ER)
House amendment agreed to by Senate (39-Y 0-N)
Read third time
VOTE: Block Vote Passage (98-Y 0-N)
Passed House with amendment BLOCK VOTE (98-Y 0-N)
Engrossed by House as amended
Committee amendment agreed to
Read second time
Reported from Labor and Commerce with amendment(s) (22-Y 0-N)
Referred to Committee on Labor and Commerce
Read first time
Placed on Calendar
Impact statement from SCC (SB98S1)
Read third time and passed Senate (38-Y 0-N)
Reading of substitute waived
Engrossed by Senate - committee substitute SB98S1
Committee substitute agreed to 24105929D-S1
Read second time
Constitutional reading dispensed (40-Y 0-N)
Impact statement from SCC (SB98)
Reported from Commerce and Labor with substitute (15-Y 0-N)
Committee substitute printed 24105929D-S1
Senate committee, floor amendments and substitutes offered
Referred to Committee on Commerce and Labor
Prefiled and ordered printed; offered 01/10/24 24101001D
Bill Text Versions | Format |
---|---|
Prefiled and ordered printed; offered 01/10/24 24101001D | PDF HTML |
Committee substitute printed 24105929D-S1 | PDF HTML |
SB98ER | PDF HTML |
CHAP0338 | PDF HTML |
Document | Format |
---|---|
Fiscal Impact Statement: SB98FER171.PDF | |
Fiscal Impact Statement: SB98FS1171.PDF | |
Fiscal Impact Statement: SB98F171.PDF | |
Amendment: SB98AHE | HTML |
Amendment: SB98AH | HTML |
Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.